Serum Anti-P53 Antibody as a Tumour Marker for Colorectal Cancer Screening

ecancermedicalscience - United Kingdom
doi 10.3332/ecancer.2015.560
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ecancer Global Foundation

Related search

NY-ESO-1 Antibody as a Novel Tumour Marker of Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

Thymidilate Synthase and P53 Primary Tumour Expression as Predictive Factors for Advanced Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2000English

Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2019English

Preoperative Serum Placenta Growth Factor Level as a New Marker for Stage II or III Colorectal Cancer Patients

Turkish Journal of Gastroenterology
Gastroenterology
2012English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Screening for Colorectal Cancer

Annals of the College of Surgeons Hong Kong
1999English

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Microsatellite Instability in Adenomas as a Marker for Hereditary Nonpolyposis Colorectal Cancer

American Journal of Pathology
Forensic MedicinePathology
1999English

Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy